Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcin Krawczyk

Showing results (201-210 of 216) with videos related to

Pageof 22
Sort By:
Gut|September 12, 2024
Identification of PRMT5 as a therapeutic target in cholangiocarcinomaJasmin Elurbide, Leticia Colyn, Maria U Latasa, et al.
Journal of Hepatology|March 3, 2023
Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinomaAinhoa Lapitz, Mikel Azkargorta, Piotr Milkiewicz, et al.
Infection|June 26, 2025
The effect of antibiotic therapy on clinical outcome in patients hospitalized with moderate COVID-19 disease: a prospective multi-center cohort studyAnette Friedrichs, Roman Wenz, Daniel Pape, et al.
Nature Communications|September 26, 2024
Decoding the diagnostic and therapeutic potential of microbiota using pan-body pan-disease microbiomicsGeorges P Schmartz, Jacqueline Rehner, Madline P Gund, et al.
Hepatology (Baltimore, Md.)|February 27, 2022
Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profilesIbon Martínez-Arranz, Chiara Bruzzone, Mazen Noureddin, et al.
Journal of Hepatology|February 15, 2022
Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA RegistryLaura Izquierdo-Sanchez, Angela Lamarca, Adelaida La Casta, et al.
Gastroenterology|May 8, 2020
Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and NoncarriersCarolin V Schneider, Karim Hamesch, Annika Gross, et al.
Hepatology (Baltimore, Md.)|October 21, 2019
Genetic Variation in HSD17B13 Reduces the Risk of Developing Cirrhosis and Hepatocellular Carcinoma in Alcohol MisusersFelix Stickel, Philipp Lutz, Stephan Buch, et al.
The Lancet Regional Health. Europe|December 16, 2025
Correction to Diagnostic accuracy and predictive value of the QuantiFERON-TB gold plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet study Lancet Reg Health Eur 57 (2025) 101416 LLRHEUROPE-D-25-00310Martina Sester, Neus Altet-Gomez, Åse Bengaard Andersen, et al.
The Lancet Regional Health. Europe|August 18, 2025
Diagnostic accuracy and predictive value of the QuantiFERON-TB gold plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet studyMartina Sester, Neus Altet-Gomez, Åse Bengaard Andersen, et al.
Pageof 22

Showing results (201-210 of 216) with videos related to

Sort By:
Pageof 22
Gut|September 12, 2024
Identification of PRMT5 as a therapeutic target in cholangiocarcinomaJasmin Elurbide, Leticia Colyn, Maria U Latasa, et al.
Journal of Hepatology|March 3, 2023
Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinomaAinhoa Lapitz, Mikel Azkargorta, Piotr Milkiewicz, et al.
Infection|June 26, 2025
The effect of antibiotic therapy on clinical outcome in patients hospitalized with moderate COVID-19 disease: a prospective multi-center cohort studyAnette Friedrichs, Roman Wenz, Daniel Pape, et al.
Nature Communications|September 26, 2024
Decoding the diagnostic and therapeutic potential of microbiota using pan-body pan-disease microbiomicsGeorges P Schmartz, Jacqueline Rehner, Madline P Gund, et al.
Hepatology (Baltimore, Md.)|February 27, 2022
Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profilesIbon Martínez-Arranz, Chiara Bruzzone, Mazen Noureddin, et al.
Journal of Hepatology|February 15, 2022
Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA RegistryLaura Izquierdo-Sanchez, Angela Lamarca, Adelaida La Casta, et al.
Gastroenterology|May 8, 2020
Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and NoncarriersCarolin V Schneider, Karim Hamesch, Annika Gross, et al.
Hepatology (Baltimore, Md.)|October 21, 2019
Genetic Variation in HSD17B13 Reduces the Risk of Developing Cirrhosis and Hepatocellular Carcinoma in Alcohol MisusersFelix Stickel, Philipp Lutz, Stephan Buch, et al.
The Lancet Regional Health. Europe|December 16, 2025
Correction to Diagnostic accuracy and predictive value of the QuantiFERON-TB gold plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet study Lancet Reg Health Eur 57 (2025) 101416 LLRHEUROPE-D-25-00310Martina Sester, Neus Altet-Gomez, Åse Bengaard Andersen, et al.
The Lancet Regional Health. Europe|August 18, 2025
Diagnostic accuracy and predictive value of the QuantiFERON-TB gold plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet studyMartina Sester, Neus Altet-Gomez, Åse Bengaard Andersen, et al.
Pageof 22